Although a US congressional panel recently blocked medical cannabis research, deciding that the federal government’s search for potential solutions to the nation’s prescription opioid crisis should not include cannabis, other countries exploring cannabis research are seeing very interesting results.
Treatments with cannabinoids have been shown to have more benefits than risks, resulting in a growing number of physicians and patients calling for more clinical research and broader use of medical cannabis.
Some important news comes from the Negev desert of southern Israel, where, according to a new study from the Ben-Gurion University (BGU), medical cannabis users experience significant pain relief and function with only minor side effects. In Israel medical cannabis has been legal for treating pain and other symptoms for over a decade, and approximately 20,000 patients have a permission to use medical cannabis.
The research team, led by Prof. Pesach Shvartzman (Faculty